NCT07336823
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Foshan First People's Hospital Foshan, Guangdong, China
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,602 public trials
545 recruiting studies
Neoplasms, Plasma Cell trial results
NCT07333430
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Hadassah MO, Jerusalem, 9574869 Jerusalem, Israel
NCT06627751
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Disease in Multiple Myeloma, +15 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT06630104
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
- Mayo Clinic Health System-Mankato Mankato, Minnesota, United States
NCT06910124
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Miami Miami, Florida, United States
NCT05722405
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Yang Xu Hangzhou, Zhejiang, China
NCT07093554
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Recruiting
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
NCT04991103
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
Recruiting
A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
NCT07312188
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
NCT07309497
- Conditions
- Bispecific Antibody, Blood Protein Disorders, CART Therapy, +18 more
- Locations
-
- Inselspital Bern Bern, Switzerland
- Universitätsspital Zürich Zurich, Switzerland